StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-06 | $20.20 | $20.25 | +0.25% | 0.0M |
| 05-07 | $20.20 | $20.38 | +0.89% | 0.0M |
| 05-11 | $20.05 | $20.35 | +1.50% | 0.0M |
| 05-12 | $20.00 | $20.36 | +1.80% | 0.0M |
| 05-13 | $20.22 | $20.30 | +0.40% | 0.0M |
EMYB reports on 2026-05-15 during the day. Things to look at before the print:
Educational pre-print checklist — descriptive only, not a directional call.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Each factor shows EMYB's percentile within the scored universe — observational ranking, not a recommendation.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $18.50M | $71.46M | $52.92M | $34.66M |
Operating Income | $4.58M | $16.60M | $12.24M | $7.64M |
Net Income | $3.74M | $13.70M | $10.12M | $3.44M |
EPS (Diluted) | $0.50 | $1.79 | $1.32 | $0.83 |
Total Assets | $1.84B | $1.80B | $1.78B | $1.76B |
Total Liabilities | $1.72B | $1.67B | $1.66B | $1.65B |
Cash & Equivalents | $141.83M | $112.86M | $108.00M | $91.82M |
Free Cash Flow OCF − CapEx | $4.66M | $12.20M | $8.45M | $4.58M |
Shares Outstanding | 7.41M | 7.55M | 7.65M | 7.65M |
No sell-side coverage available for EMYB.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
EMBASSY BANCORP INC